在多微生物败血症相关的代谢重编程和死亡中,HNF4α的关键作用
Céline Van Dender1,2, Steven Timmermans1,2, Ville Paakinaho3
1Center for Inflammation Research, VIB, Ghent, Belgium.
EMBO molecular medicine
|September 11, 2024
概括
败血症通过降低肝细胞核因子4α (HNF4α) 来损害肝功能,导致代谢问题和生存率降低. 恢复HNF4α活性为败血症提供了潜在的治疗策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
- 败血症病理生理学病理生理学
背景情况:
- 败血症会引发饥饿反应,影响能量代谢.
- 肝脏氧酶增殖器激活受体α (PPARα) 的表达在败血症下降,损害脂肪酸代谢.
- 在败血症中PPARα下调的上游机制仍然不清楚.
研究的目的:
- 研究肝细胞核因子4α (HNF4α) 在败血症引起的代谢功能障碍中的作用.
- 阐明在败血症期间将HNF4α与PPARα调节联系在一起的机制.
- 评估向HNF4α在败血症中的治疗潜力.
主要方法:
- 在败血症模型中分析肝脏HNF4α表达和功能.
- 评估HNF4α耗尽对败血症结局的影响,包括致死率,肥胖症和器官损伤.
- 评估HNF4α调制对IL6介导的急性相应反应的影响.
- 在败血症模型中测试HNF4α激动剂的疗效.
主要成果:
- 败血症会导致肝脏HNF4α的功能逐渐丧失.
- HNF4α对PPARα和其他核受体的表达至关重要.
- 缺少HNF4α会加剧败血症的死亡率,肥胖症和器官损伤.
- 缺少HNF4α会损害肝脏再生和生存所必需的IL6反应.
- 一种HNF4α激动剂证明了对败血症的保护作用,无论细菌负载如何.
结论:
- 在败血症期间,肝脏HNF4α活性显著降低.
- 降低HNF4α导致PPARα下调,代谢障碍和急性阶段反应受损.
- HNF4α在败血症耐受性方面发挥着至关重要的作用,是有前途的治疗点.
相关概念视频
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K


